Opinions Jim Cramer - Mad Money
Medline MDLNBUYJan 07, 2026
Jim Cramer - Mad MoneyUnknown
N/A
Stock price when the opinion was issued
Healthcare
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
BUY ON WEAKNESS
It went public today. Through the first 9 months of 2025: 9.8% net sales growth and 12.9% adjusted EBITDA margin. Boasts sold revenue growth in recent years and has a decent, not great, balance sheet. Those buying shares today will have little voting power while existing shareholders will hold 80% of the vote. Today, shares closed +41% above the offers price, so the share price is rich. Trades at roughly 45x PE, which is high for low double-digit growth. Likes this, but buy at $29-30.
Healthcare
Is up 39.4% since its IPO last month. Though off its highs, it looks healthy and is better than many IPOs last year.